Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
3.49 USD -0.29% Intraday chart for Werewolf Therapeutics, Inc. -32.50% -9.59%
Jun. 01 Werewolf Therapeutics to Present Data from Ongoing Phase 1/1B Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors CI
May. 23 Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. News Werewolf Therapeutics, Inc.
  5. Official Publications